Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (NYSE:CVS) with a target price of $47.00.
CVS Caremark reported first quarter 2012 EPS of 59 cents, up 13.5% year over year. However, after excluding the impact of certain one-time items from both the periods, adjusted EPS came in at 65 cents, surpassing the Zacks Consensus Estimate of 63 cents and up 14.0% year over year. Net revenue during the quarter increased 19.9% year over year to $30.8 billion, marginally beating … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards